Recent Regulatory Developments India’s biopharmaceutical industry stands at an inflection point where its scientific capabilities and production scale are increasingly recognized globa...
Key Highlights: Implications: Quality failures erode trust in high-volume generics, handing innovator brands a compliance advantage as hospitals pivot to verified suppliers. Tie...
